New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here’s why
Pfizer, Moderna and Novavax are slated to deliver new single-strain Covid shots targeting the omicron subvariant XBB.1.5 in September. Source
Read More
Vaccinations
Pfizer Group B strep vaccine for infants returns encouraging mid-stage trial results
Pfizer is among several drugmakers racing to develop the world's first shot targeting Group B strep disease, which kills thousands
Read More
Covid vaccine maker Novavax sees a pathway to survival – but it won’t be easy
Cash-strapped Covid vaccine Novavax still faces a nunber of challenges, chiefly competing with Pfizer and Moderna in the U.S. commercial
Read More
FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns
The FDA is slated to make a decision on whether to approve Pfizer's shot in August before respiratory syncytial virus
Read More
FDA approves GSK’s RSV vaccine for older adults, world’s first shot against virus
The FDA's approval is a victory for GSK in a race against Pfizer and Moderna to bring a shot that
Read More
FDA says Guillain-Barre syndrome is possible risk of Pfizer’s RSV vaccine for older adults
The FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential
Read More
Mainland Chinese citizens are eager to travel — for the West’s mRNA Covid vaccines
Mainland China has reopened its borders, and citizens eager to travel are booking not just flight tickets, but also vaccination
Read More
‘Once-in-a-generation’ prescription drug pricing reform could be coming. Here’s what we know
A Democratic bill calls for letting Medicare negotiate the price of prescription drugs. The change may result in significant savings
Read More
President Joe Biden likely has BA.5 variant but Covid-19 symptoms ‘continue to improve,’ doctor says
President Joe Biden likely has the BA.5 Covid-19 variant but symptoms "continue to improve," according to the White House. Source link
Read More